423 related articles for article (PubMed ID: 2456372)
1. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.
Rosenberg AS; Mizuochi T; Singer A
J Exp Med; 1988 Jul; 168(1):33-45. PubMed ID: 2456372
[TBL] [Abstract][Full Text] [Related]
2. In vivo induction of antigen-specific transplantation tolerance to Qa1a by exposure to alloantigen in the absence of T-cell help.
Rees MA; Rosenberg AS; Munitz TI; Singer A
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2765-9. PubMed ID: 2138785
[TBL] [Abstract][Full Text] [Related]
3. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.
Rosenberg AS; Mizuochi T; Sharrow SO; Singer A
J Exp Med; 1987 May; 165(5):1296-315. PubMed ID: 2437237
[TBL] [Abstract][Full Text] [Related]
4. Differential helper and effector responses of Lyt-2+ T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness.
Mizuochi T; Munitz TI; McCarthy SA; Andrysiak PM; Kung J; Gress RE; Singer A
J Immunol; 1986 Nov; 137(9):2740-7. PubMed ID: 2944960
[TBL] [Abstract][Full Text] [Related]
5. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
[TBL] [Abstract][Full Text] [Related]
6. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
Rosenberg AS; Munitz TI; Maniero TG; Singer A
J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
[TBL] [Abstract][Full Text] [Related]
7. Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
J Exp Med; 1990 Jul; 172(1):105-13. PubMed ID: 2141624
[TBL] [Abstract][Full Text] [Related]
8. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
Mizuochi T; Ono S; Malek TR; Singer A
J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
[TBL] [Abstract][Full Text] [Related]
9. Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self.
Mizuochi T; Golding H; Rosenberg AS; Glimcher LH; Malek TR; Singer A
J Exp Med; 1985 Aug; 162(2):427-43. PubMed ID: 3160804
[TBL] [Abstract][Full Text] [Related]
10. Assessment of alloreactive T cell subpopulations of aged mice in vivo. CD4+ but not CD8+ T cell-mediated rejection response declines with advanced age.
Rosenberg AS; Sechler JM; Horvath JA; Maniero TG; Bloom ET
Eur J Immunol; 1994 Jun; 24(6):1312-6. PubMed ID: 7911422
[TBL] [Abstract][Full Text] [Related]
11. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
Clement JD; Chan SY; Bishop DK
Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
[TBL] [Abstract][Full Text] [Related]
13. Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC.
Rosenberg AS; Mizuochi T; Singer A
Nature; 1986 Aug 28-Sep 3; 322(6082):829-31. PubMed ID: 3528862
[TBL] [Abstract][Full Text] [Related]
14. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
15. T helper cells in cytotoxic T lymphocyte development: analysis of the cellular basis for deficient T helper cell function in the L3T4-independent T helper cell pathway.
Ciavarra RP
Cell Immunol; 1991 May; 134(2):427-41. PubMed ID: 1850663
[TBL] [Abstract][Full Text] [Related]
16. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
Rosenberg AS; Katz SI; Singer A
J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
[TBL] [Abstract][Full Text] [Related]
17. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
[TBL] [Abstract][Full Text] [Related]
18. Tolerance induction of allo-class I H-2 antigen-reactive Lyt-2+ helper T cells and prolonged survival of the corresponding class I H-2-disparate skin graft.
Azuma T; Sato S; Kitagawa S; Hori S; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Jul; 143(1):1-8. PubMed ID: 2525143
[TBL] [Abstract][Full Text] [Related]
19. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
Halliday GM; Odling KA; Muller HK
Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
[TBL] [Abstract][Full Text] [Related]
20. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
